Int. J. Radiat. Oncol. Biol. Phys. 2006-01-01
Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time.
Abstract
Purpose
To investigate in a prospective randomized study the effect of radiation fraction size and overall treatment time on the local control of early glottic carcinoma.
Methods and materials
Between December 1993 and December 2001, 180 patients with early glottic carcinoma (T1N0M0) were treated at our department. The patients were randomly allocated to either treatment arm A (radiation fraction size 2 Gy, n = 89) or B (2.25 Gy, n = 91). The total radiation dose administered was 60 Gy in 30 fraction within 6 weeks for minimal tumors (two-thirds of the vocal cord or less) or 66 Gy in 33 fractions in 6.6 weeks for larger than minimal tumors (more than two-thirds of the vocal cord) in Arm A and 56.25 Gy in 25 fractions within 5 weeks for minimal tumor or 63 Gy in 28 fractions within 5.6 weeks for larger than minimal tumors in Arm B.
Results
The 5-year local control rate was 77% for Arm A and 92% for Arm B (p = 0.004). The corresponding 5-year cause-specific survival rates were 97% and 100% (no significant difference). No significant differences were found between these two arms in terms of rates of acute mucosal reaction, skin reactions, or chronic adverse reactions.
Conclusion
Use of 2.25-Gy fractions with a shorter overall treatment time for Arm B showed superior local control compared with conventional use of 2-Gy fractions for Arm A without adverse reactions from the greater fraction.
Related Questions
What RT dose do you recommend for carcinoma in situ of the glottic larynx?
I use 2.25 Gy/fx per the Yamazaki randomized trial (PMID: 16169681), 56.25 Gy to 63 Gy depending on lesion bulk. Sometimes the laryngeal biopsy may not have been deep enough to detect invasion or only a portion of a larger lesion was biopsied, leaving the possibility of invasion remaining. We discus...
Have we established standard doses for radiation therapy for H&N cancers?
You've asked a *really* wide-ranging, thought-provoking question. That said, if by 70 Gy you mean 35 fractions of 2 Gy apiece over 7 weeks as *the* "optimal dose," I can think of a few references off the top of my head where that's not optimal per se. Dosing also entails the timing/frequency of dose...
What is the optimal dose and fractionation of RT for a T2N0 laryngeal SCC?
Great question. The data for accelerated fractionation (AFX) vs. hyperfractionation (HFX) vs. standard fractionation for T2 is a bit difficult to parse.At a basic level, we all recognize that T2 larynx spans a range from pts just a bit larger than T1 TVC cases, who could expect >90% survival with RT...